IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q2 2024 Holdings

Filed 2024-08-08 | 3 holdings | $33.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Coherus Biosciences IncNOTE 1.500% 4/119249HAB9$22.2M$30,000,00066.3%
Biora Therapeutics Inc.COM NEW74319F305$7.2M10,929,76221.5%
Puma Biotechnology Inc(PBYI)COM74587V107$4.1M1,256,41112.2%